Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gael S Roth

10PUBLICATIONS
48CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Dec 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?

Gael S Roth, François Villeret, Thomas Decaens

|Dec 23, 2022
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.

Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth

|Nov 11, 2022
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.

Gaël S Roth, Yohan Fayet, Sakina Benmameche-Medjahed

|Jul 12, 2022
SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

Valentina Lukinović, Simone Hausmann, Gael S Roth

|Apr 12, 2022
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma.

Gael S Roth, Olivier Hernandez, Najeh Daabek

|Nov 06, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functions.

Sonia Brun, Eloïne Bestion, Eric Raymond

Pageof 2

Frequent Collaborators

6 joint publications

Thomas Decaens

3 joint publications

Zuzana Macek Jílková

2 joint publications

Patrice N Marche

1 joint publications

Hervé Lerat

1 joint publications

Angelica Petrillo

1 joint publications

Michele Ghidini

1 joint publications

Julien Taieb

1 joint publications

Marie-Hélène Laverriere

1 joint publications

Arnaud Millet

1 joint publications

Sonia Brun

Frequent Collaborators

6 joint publications

Thomas Decaens

3 joint publications

Zuzana Macek Jílková

2 joint publications

Patrice N Marche

1 joint publications

Hervé Lerat

Top Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

9.0K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on : Apr 15, 2016

9.6K
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

890
See more related videos

Top Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

9.0K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on : Apr 15, 2016

9.6K
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

890
See more related videos